Description

Simple

Clinical

Overview

Hexoprenaline is a stimulant of beta 2 adrenergic receptors. It is used as a bronchodilator, antiasthmatic, and tocolytic agent.

Pharmacology

Indication

Information currently not available.

Pharmacodynamic

Information currently not available.

Mechanism of action

Information currently not available.

Absorption

Information currently not available.

Protein binding

Information currently not available.

Volume of distribution

Information currently not available.

Clearance

Information currently not available.

Half life

Information currently not available.

Route of elimination

Information currently not available.

Toxicity

Information currently not available.

Adverse Effects

Contraindications

Information currently not available.

Food Interactions

    Information currently not available.

Interactions

Type in a drug name to check for interaction with Hexoprenaline
Type a drug name in the box above to get started
  • Paracetamol(acetaminophen)
  • Paxil(paroxetine)
  • Pamelor(nortriptyline)
  • Panadol(acetaminophen)
  • Patanol(olopatadine ophthalmic)
  • Pataday(olopatadine ophthalmic)
  • Parnate(tranylcypromine)
  • Pazeo(olopatadine ophthalmic)
1-benzylimidazole
The risk or severity of hypertension can be increased when 1-benzylimidazole is combined with Hexoprenaline.
2,5-Dimethoxy-4-ethylamphetamine
The risk or severity of hypertension can be increased when 2,5-Dimethoxy-4-ethylamphetamine is combined with Hexoprenaline.
2,5-Dimethoxy-4-ethylthioamphetamine
The risk or severity of hypertension can be increased when Hexoprenaline is combined with 2,5-Dimethoxy-4-ethylthioamphetamine.
4-Bromo-2,5-dimethoxyamphetamine
The risk or severity of hypertension can be increased when 4-Bromo-2,5-dimethoxyamphetamine is combined with Hexoprenaline.
4-Methoxyamphetamine
The risk or severity of hypertension can be increased when 4-Methoxyamphetamine is combined with Hexoprenaline.
5-methoxy-N,N-dimethyltryptamine
The risk or severity of hypertension can be increased when Hexoprenaline is combined with 5-methoxy-N,N-dimethyltryptamine.
7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline
The risk or severity of adverse effects can be increased when 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline is combined with Hexoprenaline.
Abediterol
The risk or severity of adverse effects can be increased when Hexoprenaline is combined with Abediterol.
Acebutolol
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Acebutolol.
Aceclofenac
The risk or severity of hypertension can be increased when Aceclofenac is combined with Hexoprenaline.
Acemetacin
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Acemetacin.
Acepromazine
The therapeutic efficacy of Hexoprenaline can be decreased when used in combination with Acepromazine.
Acetylsalicylic acid
The risk or severity of hypertension can be increased when Acetylsalicylic acid is combined with Hexoprenaline.
Aclidinium
The risk or severity of Tachycardia can be increased when Aclidinium is combined with Hexoprenaline.
Adenosine
The risk or severity of Tachycardia can be increased when Adenosine is combined with Hexoprenaline.
Adrafinil
The risk or severity of hypertension can be increased when Adrafinil is combined with Hexoprenaline.
Ajulemic acid
The risk or severity of Tachycardia can be increased when Hexoprenaline is combined with Ajulemic acid.
Alclofenac
The risk or severity of hypertension can be increased when Hexoprenaline is combined with Alclofenac.
Aldosterone
The risk or severity of hypokalemia can be increased when Aldosterone is combined with Hexoprenaline.
Alfentanil
The risk or severity of hypertension can be increased when Alfentanil is combined with Hexoprenaline.
1 References
  1. 1 . Pinder RM, Brogden RN, Speight TM, Avery GS: Hexoprenaline: a review of its pharmacological properties and therapeutic efficacy with particular reference to asthma. Drugs. 1977 Jul;14(1):1-28.PubMed: 195789